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cations, the last being a consequence of long-term anti-
coagulation.2-5 Even though biologic valves do not
require long-term anticoagulation, they are not free of
other complications observed with mechanical valves.
In addition, biologic valves show structural damage
from the seventh year after implantation,3,5 and if the
aortic root is small, an anulus-enlargement procedure
should precede the placement of a biologic valve.
Aortic valve debridement appeared to be an alterna-
tive treatment for severe aortic stenosis,6 but it was
abandoned because of the high short- and long-term
incidence of restenosis and aortic regurgitation, espe-
cially when the ultrasonic technique was used.7,8
Few data have been published regarding manual aor-
tic valve debridement in the elderly.9 We thus aimed to
assess short- and long-term results of manual debride-
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tic valve replacement has modified the prognosis of this
disease, the use of mechanical valves is not free of
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Objective: We prospectively analyzed the short- and long-term results of
manual debridement of the aortic valve in elderly patients with severe
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stenosis underwent the manual debridement technique. All had symp-
toms (angina or dyspnea, or both). Peak systolic gradient was 89 ± 28
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ease necessitating revascularization. Results: Follow-up time was 42 ± 21
months (range 3-98 months). The Kaplan-Meier estimated survival at 98
months was 50% (95% CI: 30%-70%). In-hospital mortality was 5.8%
(6 patients), and late mortality was 21% (21 patients). No predictors of
in-hospital mortality or of late mortality were detected. Nonfatal post-
operative complications appeared in 25 patients (24%). At 8 years, free-
dom from endocarditis was 98% (95% CI: 95%-100%) and freedom
from thromboembolic events was 99% (95% CI: 96%-100%). No
patient required long-term anticoagulation as a result of the procedure.
Fourteen patients (14%) required reoperation for aortic insufficiency (n
= 5), restenosis (n = 8), and mitral regurgitation (n = 1). The probabili-
ty of reoperation at 98 months was 23% (95% CI: 12%-35%).
Conclusion: Manual aortic valve debridement has low rates of in-hospi-
tal mortality, perioperative complications, and thromboembolic and
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the incidence of restenosis and reoperation is high in the long term. It
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MANUAL DEBRIDEMENT OF THE AORTIC VALVE IN ELDERLY PATIENTS WITH DEGENERATIVE 
AORTIC STENOSIS
ment of the aortic valve as a treatment for degenerative
aortic stenosis in aged patients with favorable anatom-
ic conditions to perform this procedure (no valvular
distortion and calcific lumps only on the aortic surface
of the cusps), some of whom had a small aortic root
with or without associated coronary artery disease.
Patients and methods
Between September 1988 and January 1997, 103 patients
with degenerative aortic stenosis underwent manual debride-
ment of the aortic valve. Mean age was 73.7 ± 6 years (range
65-87 years), and 57 patients (55%) were women. We select-
ed some patients in whom the procedure was technically
viable—patients with well preserved valvular architecture
and calcium deposits only on the aortic surface of the cusps.
Some of these patients had a small aortic root that would have
necessitated prior enlargement of the outflow tract to allow
placement of a bioprosthesis of at least 23 mm, and some oth-
ers had combined coronary artery disease and moderate-to-
severe aortic stenosis. Patients younger than 65 years, those
with aortic stenosis of rheumatic etiology, and those having
aortic regurgitation of more than 2+/4 were excluded from
this technique and subjected to valve replacement. Table I
shows the clinical features of the population. All patients
underwent coronary angiography. In 41 patients (40%), sig-
nificant coronary artery disease was documented.
Surgical technique. All patients underwent manual
debridement of the aortic valve. The procedure was always
done by the same surgeon, using No. 15 scalpel blades, dis-
secting forceps, and rongeur forceps. Removal of the calcium
lumps from the fibrous matrix of the cusps was started with a
slight torsion movement with a rongeur forceps. Thereafter,
removal was completed by careful dissection with the use of
delicate pickups until the lump remained adherent to the
leaflet by a thin endothelial layer, which was finally cut with
scissors. This maneuver was done with great care, because
any piercing of the leaflet would have resulted in failure of
the repair. Occasionally, the calcium deposits reached the
valvular anulus and even the site of insertion of the cusps. If
these deposits were lumps, they were removed by means of
the technique just described, but if they were firm calcific
plaques extending to the aortic wall, we removed them only
if they restricted the movement of the cusps. The procedure
was ended when all calcium was removed and the 3 cusps
were mobile enough to contact the aortic wall, thus ensuring
significant reduction of the gradient.
In patients undergoing myocardial revascularization, 1.9
grafts per patient were done. The internal thoracic artery was
used in 30 patients (73%) and a free radial artery graft in 1
(2.3%).
In 2 patients (1.9%) with severe mitral regurgitation, annu-
loplasty with bovine pericardium was performed.
In 2 patients (1.9%), a minithoracotomy with a vertical
incision through the third and fourth right costal cartilages
was carried out, whereas in the others conventional thoracot-
omy was used.
Follow-up. Clinical and echocardiographic studies were
performed in all patients just before discharge, at 6 months
and 1 year after the operation, and every year thereafter.
Hospital mortality was defined as death occurring within 30
days after the operation. During long-term follow-up the fol-
lowing events were assessed: death, reoperation, thromboem-
bolism, infectious endocarditis of the treated valve, resteno-
sis, and aortic regurgitation.
Peak transvalvular gradients, chamber diameters, the
degree of aortic regurgitation, and left ventricular systolic
function were assessed by means of Doppler echocardiogra-
phy. Aortic regurgitation was classified as mild (1+/4), mod-
erate (2+/4), moderate to severe (3+/4), and severe (4+/4).
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Table I. Baseline characteristics of the population
Characteristic No. %
Age (y)
Mean 73.7 ± 6
Range 65-87
65-69 25 24
70-79 61 59
80-86 17 17
Sex
Male 46 45
Female 57 55
Diabetes 10 10
NYHA functional class
II 39 38
III 34 33
IV 17 16
Angina II 24 23
Angina III-IV 29 28
Syncope 10 10
Preoperative rhythm
Sinus 93 90
Atrial fibrillation 10 10
Coronary artery disease 41 40
Left main 6 6
Previous myocardial infarction 6 6
NYHA, New York Heart Association.
Table II. In hospital complications
AD 
All AD combined 
Cause (n = 103) (n = 61) (n = 42)
Cardiac complications 17 (16%) 8 (13%) 9 (21%)
Heart failure 3 (2.9%) 2 (3.2%) 1 (2.3%)
Atrial fibrillation 11 (11%) 7 (11%) 4 (9%)
Ventricular tachycardia 3 (2.9%) 1 (1.6%) 2 (5%)
Noncardiac complications 13 (13%) 7 (11%) 6 (14%)
Stroke 3 (2.9%) 1 (1.6%) 2 (4.7%)
Renal failure 4 (3.8%) 2 (4.9%) 2 (4.7%)
Bleeding 3 (2.9%) 2 (3.2%) 1 (2.3%)
Infection 3 (2.9%) 2 (3.2%) 1 (2.3%)
AD, Aortic debridement; AD combined, aortic debridement combined with
additional procedures.
Statistics. The estimates of the survival curves and their
standard errors were computed by means of the Kaplan-
Meier method and the Greenwood formula. We plotted a rep-
resentation of the distribution of the survival time until reop-
eration, the cumulative incidence curve.10,11 This plot has a
simple meaning for both independent and dependent end
points. If we call T the time until the first observed end point,
the cumulative incidence function is defined as follows:
F (t) = P (the end point observed is reoperation and T ≤ t) =
P (reoperation occurred by time t).
The log-rank test was used to assess differences between
groups. Cox regression models were used for multivariate
analysis. 
Postoperative transvalvular gradients were modeled with a
linear mixed model of the following form:
gij = (b 0 + b 1 tj + b 2 tj2 ) + (bi0 + bil tj + bi2 tj2) + e ij
where gij is the observed gradient for the ith patient at time tj;
b 0, b 1, and b 2 are population polynomial coefficients, and bi
= (bi0, bil, bi2) allows the coefficients to change for each
patient. The vectors bi are assumed to be independent and
normally distributed, with a mean value of zero and an arbi-
trary covariance matrix. The terms e ij are independent normal
errors. The procedure lme of S-Plus version 4.5 (MathSoft,
Inc, Seattle, Wash) was used to fit this model.
Results
In 61 patients (59%) only aortic debridement was
done. In 40 patients (39%) with associated coronary
artery disease, aortic debridement plus myocardial
revascularization was performed. In 2 patients (1.9%),
debridement plus mitral valve repair was done, 1 of
them also undergoing myocardial revascularization.
Two patients were excluded from the study because
of unsuccessful debridement (valve perforation greater
than 5 mm in both cases) and conversion to valve
replacement.
The duration of extracorporeal circulation and aortic
crossclamping was 65 ± 21 and 47 ± 17 minutes,
respectively, in patients undergoing valvular debride-
ment only and 95 ± 16 and 70 ± 16 minutes in those
with combined myocardial revascularization and/or
mitral valve repair.
In-hospital mortality. Overall in-hospital mortality
was 5.8% (6 patients). Of the 61 patients undergoing
only aortic valve debridement, 3 (4.9%) died. Three
(7.1%) of 42 patients subjected to combined proce-
dures died: 2 of these underwent myocardial revascu-
larization, and 1 revascularization with combined
mitral valve repair. In 3 patients the cause of death was
of cardiac nature: ventricular tachycardia in 2 and car-
diogenic shock in 1. The remaining 3 died of sepsis,
stroke, and renal failure, respectively. Statistical analy-
sis of the diverse clinical, angiographic, hemodynamic,
and surgical variables did not identify any of them as a
predictor of in-hospital mortality.
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Fig 1. Estimates of survival ± standard error for all patients including hospital deaths.
In-hospital morbidity. Nonfatal complications
appeared in 25 patients (24%) (Table II), the most fre-
quent being atrial fibrillation (11 patients, 11%). No
patient had atrioventricular or intraventricular conduc-
tion disturbances necessitating implantation of a per-
manent pacemaker.
Follow-up. Mean follow-up time was 42 ± 21
months (range 3-98 months). Late mortality was 21%
(21 patients), principally in those subjected to com-
bined procedures.
The estimated survival at 4 and 8 years was 74%
(95% CI: 64%-84%) and 50% (95% CI: 30%-70%)
(Fig 1). Patients undergoing only valve debridement
had a higher Kaplan-Meier survival curve than those
having valve debridement combined with coronary
artery bypass grafting (80% vs 65% at 4 years and 60%
vs 35% at 8 years; Fig 2), but the difference is not sta-
tistically significant (P = .27). The causes of late mor-
tality are listed in Table III. Cox regression analysis
was unable to detect any predictor of late mortality.
At 11 months, 1 patient had a stroke and, although
the cause could not be established, it was considered to
be related to the valve. Stroke occurred in 2 more
patients at 22 and 24 months. In these, stroke was
attributed to carotid artery disease and the patients
underwent carotid endarterectomy. In the 98-month
follow-up period, freedom from thromboembolic
events was 99% (95% CI: 96%-100%). No patient
required anticoagulation because of the surgical proce-
dure. In 3 patients, anticoagulation was indicated
because of chronic atrial fibrillation. One patient had
aortic valve endocarditis after erysipelas. In the 98-
month follow-up period, freedom from endocarditis
was 98% (95% CI: 95%-100%). 
Gradients at the sixth postoperative month were
much lower than those measured before the operation.
It should be noticed that in all patients the gradient had
decreased 6 months after the operation (Table IV).
In the long term, the gradient increased (P < .0001;
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Fig 2. Comparison of the estimated survival for 2 groups of patients: with aortic valve debridement only and with
aortic valve debridement combined with coronary artery bypass grafting (CABG).
Table III. Cause of late mortality
Cause No. %
Cardiac related 10 48
Reoperation 2 9
Sudden 6 28
Unknown 2 9
Noncardiac related 11 52
Cancer 7 33
Infection 2 9
Renal failure 1 4.7
Diabetes 1 4.7
Fig 3). As seen, this increase is nonlinear, the rate of
increase being greater during the first years. To see if
this observation could be due to random variations, we
adjusted a second-degree polynomial. The polynomial
adjusted was as follows: mean gradient = 16.8 + 17.3 ·
time–1.26 · time2 (P value for the quadratic term <
.0001). Therefore we conclude that the gradient does
not have a linear relation with time, but its derivative
decreases with time.
Table IV shows that when 1 period is compared with
the following period, almost all patients exhibit an
increasing gradient. If, instead of comparing consecu-
tive periods, the value observed in 1 year is compared
with that observed 2 years earlier (not shown in Table
IV), the gradient increases in all patients, without
exceptions. When the measurement at 6 months is
compared with that taken after 4 years, the mean vari-
ation for the 24 patients undergoing both measure-
ments is 36.5 ± 13.4 mm Hg (range 15-61 mm Hg).
In the early patients of this series, aortic regurgitation
was an important cause of reoperation. Table V shows
the evolution of aortic regurgitation: after 6 months, the
degree of aortic regurgitation had increased in 50 of 83
patients. In some patients, regurgitation continued to
worsen for 1 year after the operation. Thereafter,
almost no patient exhibited variations. 
All patients had an improvement in functional class
of dyspnea or angina (or both) at 6 months and, despite
the increase in gradient, most patients remained free of
symptoms, the exception being those who required
reoperation (Table VI).
Reoperations. Fourteen patients (14%) had reopera-
tions, 5 (5.1%) because of severe aortic regurgitation
and 8 (8%) because of restenosis. In 1 patient (1%),
reoperation was indicated because of severe mitral
regurgitation, and during the same operation the aortic
valve was replaced because of signs of recalcification.
All reoperations were indicated because of the pres-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 6
Weinschelbaum et al   1161
Table IV. Transvalvular gradient variation between two consecutive measurements
Pre-0.5 y 0.5-1 y 1-2 y 2-3 y 3-4 y 4-5 y 5-6 y 6-7 y 7-8 y
No. of patients 88 70 49 34 23 12 8 6 3
Peak AVG (mm Hg) –63.7 11.9 8.9 10.5 9.1 8.5 6.6 4.2 6.7
SD 24.5 8.3 9.9 10.2 6.3 4.9 6 1.3 1.5
Patients with variation > 0 mm Hg 0 66 45 28 22 12 6 6 3
AVG, Aortic valve gradient; SD, standard deviation; y, years.
Fig 3. Mean transvalvular gradient (± SE) as a function of time.
ence of symptoms. At 98 months of follow-up, 69% of
the patients were free of reoperations (Fig 4). The prob-
ability of reoperation at 4 and 8 years was 15% (95%
CI: 6%-24%) and 23% (95% CI: 12%-35%), respec-
tively (Fig 5). During follow-up, reoperations necessi-
tated by regurgitation showed a tendency to occur ear-
lier than those necessitated by restenosis. After 3 years
of follow-up, the only reason for reoperation was
stenosis. Two patients died during reoperation.
Discussion
Several studies have demonstrated that a small-sized
aortic bioprosthesis has an unfavorable hemodynamic
performance with high residual transvalvular gradi-
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Table V. Aortic regurgitation, variations with time
Years from operation
Before operation 0.5 y 1 y 2 y 3 y 4 y 5 y 6 y 7 y 8 y
Aortic regurgitation
No. of patients 89 90 70 47 34 23 12 8 6 3
0/4+
No. 47
% 53%
1/4+
No. 42 61 37 27 24 12 8 6 1 2
% 47% 69% 53% 57% 71% 52% 67% 75% 83% 67%
2/4+
No. 18 24 16 6 7 2 1
% 20% 34% 34% 18% 30% 17% 12%
3/4+
No. 7 6 3 3 4 2 1 1
% 8% 11% 6% 9% 17% 17% 12% 33%
4/4+
No. 4 3 1 1 1
% 4% 6% 2% 3% 17%
Comparison between 2 consecutive postoperative measures
No. of patients with variation
=0 33 52 43 29 19 12 8 5 2
>0 50 16 2 1 3 1
y, Years.
Table VI. NYHA functional class of dyspnea or angina variations with time
Years from operation
0.5 y 1 y 2 y 3 y 4 y 5 y 6 y 7 y 8 y
Variations with time
No. of patients 91 70 50 37 22 13 9 7
Class I
No. 85 65 45 31 17 11 8 6 2
% 93% 93% 90% 83% 77% 85% 89% 86% 67%
Class II
No. 6 4 5 5 5 2 1 1 1
% 7% 6% 10% 14% 23% 15% 11% 14% 33%
Class III
No. 1 1
% 1% 3%
Comparison between 2 consecutive postoperative measures
No. of patients with variations
0 5 66 46 31 19 11 8 6 2
> 0 4 3 5 3 1 1 1
< 0 86 1 1 1
NYHA, New York Heart Association; y, years.
ents.12-14 Insertion of a larger valve requires prior root
enlargement, but this prolongs the duration of the operation
and may increase the operative risk in older patients.15
Stentless aortic xenografts, which have appeared recently,
have not yet been tested in the long term.16
Aortic valve debridement is a surgical technique that
has been questioned on the basis of the results report-
ed.7-9 However, some authors have suggested the use-
fulness of this method in elderly patients who have a
small aortic anulus.17 The anatomopathologic charac-
teristics of these valves suggest that this technique may
be useful to restore valvular motility and decrease the
transvalvular gradient without inducing incompetence.
The lesser degree of distortion with regard to other
causes, the minimal leaflet retraction observed in most
cases, and the fact that the commissures are preserved
allow debridement of the valvular surface without dis-
torting the original architecture.18
In the present series, a low in-hospital mortality rate
was observed, both for the patients subjected to the
procedure alone and for those undergoing combined
myocardial revascularization. Such rates are compara-
ble with those reported for valve replacement, which
range from 4.4% to 18%.19-23 Other studies reporting
the use of this technique are not strictly comparable
with the present one because they include diverse caus-
es and age groups.6-8
The incidence of nonfatal postoperative complica-
tions was approximately 25%, significantly less than
that reported in studies of valve replacement. Aranki
and coworkers21 reported a 48% incidence, 10% of
which was directly related to the valve.
We did not observe any complication related to the
valve, and no patient required anticoagulation associat-
ed with the procedure. In patients with biologic pros-
theses and no anticoagulation, Heras and colleagues24
observed that the incidence of thromboembolic events
between the first and tenth days after surgery was 41%
per year and between the eleventh and ninetieth post-
operative days, 3.6% per year. On the basis of these
results and those of others,5,25 the need for anticoagula-
tion during the first 3 months after surgery was sug-
gested. However, in elderly patients, the reported inci-
dence of bleeding is 9% per patient-year.15
Aortic valve replacement is associated with a 3.2% to
5.6% incidence of conduction disturbances necessitat-
ing permanent pacing.26,27 In our series, no patient
required implantation of a permanent pacemaker
because of conduction disturbances induced by the pro-
cedure. Reduced trauma on the valvular anulus and the
absence of sutures probably explain why conduction
disturbances did not occur.
Survival at 4 and 8 months was similar to that ob-
served in aged patients undergoing valve replacement
The Journal of Thoracic and
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Fig 4. Estimated survival free from reoperation assuming that death is independent of reoperation.
with biologic prostheses.19,28 Patients undergoing only
valve debridement had higher survivals than those with
combined myocardial revascularization. Similar results
were reported by other authors.29,30
Freedom from endocarditis and thromboembolic
events in our experience was higher than that reported
for similar time periods in patients receiving biologic
prostheses.22,23,31
Despite similar survivals and probably a lower inci-
dence of infectious and thromboembolic events, in the
long-term follow-up both the need for reoperations and
the structural damage of the valve are higher in our
experience higher with biologic prostheses. With bio-
logic prostheses, freedom from reoperation at 10 years
is approximately 76% to 91% and freedom from struc-
tural valve deterioration, 89% to 91%.23,31
Since our technique is essentially manual, we believe
that the higher overall incidence of reoperations in our
series was influenced by suboptimal technique in the
early patients. During the first 3 years, the main cause
of reoperation was severe aortic regurgitation. It should
be noticed, however, that this complication was preva-
lent in our early patients and did not occur again after
the technique had been corrected. Late reoperations, on
the other hand, are not attributable to technical prob-
lems, but to recalcification and restenosis.
Echocardiographic follow-up evidenced a progressive
increase in peak gradient values and restricted valve
motility. Two different types of outcomes were ob-
served: valvular restenosis necessitating surgery rapidly
developed within 3.5 years in 1 group; in others, the pro-
gression was slower, with milder increase of transvalvu-
lar gradient values. We were unable to detect preopera-
tive values related to these types of progression. 
Moderate-to-severe and severe residual valvular
regurgitation (a complication related to the early cases)
at 6 months was 11.3%. With ultrasound debridement,
the reported development of severe and moderate aor-
tic insufficiency at 9 months after surgery is 26% and
37%, respectively.32 These differences with regard to
our own results probably are due to the lesser scar
effect generated by manual debridement.
Ninety-eight percent of the patients showed improve-
ment in functional capacity in the postoperative study
despite progressive increase of the transvalvular gradi-
ent. A dissociation was observed between the increase
in transvalvular gradient and functional capacity, the
latter remaining stable during follow-up. Despite its
progressive increase, the transvalvular gradient was
lower than the preoperative value. This could explain
the dissociation between the increase in the gradient
and the stability of the functional class.
Conclusion 
Manual aortic valve debridement has low rates of in-
hospital mortality, perioperative complications, and
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Fig 5. Probability of reoperation by time t ± standard error (SE).
thromboembolic and infectious events, and no need for
anticoagulation. However, it has a high incidence of
restenosis and reoperation in the long term. It may
therefore be said that this procedure is useful in aged
patients with favorable valve anatomy (no distortion
and calcium deposits only on the aortic surface of the
cusps), especially those with a small aortic anulus,
associated coronary artery disease, or contraindication
for anticoagulation.
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